GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (OTCPK:SUVPF) » Definitions » Cyclically Adjusted PB Ratio

SUVPF (Sartorius AG) Cyclically Adjusted PB Ratio : 8.99 (As of May. 30, 2025)


View and export this data going back to . Start your Free Trial

What is Sartorius AG Cyclically Adjusted PB Ratio?

As of today (2025-05-30), Sartorius AG's current share price is $259.02. Sartorius AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $28.80. Sartorius AG's Cyclically Adjusted PB Ratio for today is 8.99.

The historical rank and industry rank for Sartorius AG's Cyclically Adjusted PB Ratio or its related term are showing as below:

SUVPF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 7.63   Med: 20.67   Max: 84.11
Current: 8.85

During the past years, Sartorius AG's highest Cyclically Adjusted PB Ratio was 84.11. The lowest was 7.63. And the median was 20.67.

SUVPF's Cyclically Adjusted PB Ratio is ranked worse than
91.94% of 496 companies
in the Medical Devices & Instruments industry
Industry Median: 1.82 vs SUVPF: 8.85

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sartorius AG's adjusted book value per share data for the three months ended in Mar. 2025 was $42.430. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $28.80 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sartorius AG Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sartorius AG's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Cyclically Adjusted PB Ratio Chart

Sartorius AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.14 49.56 26.59 17.25 9.07

Sartorius AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.85 10.40 11.12 9.07 8.53

Competitive Comparison of Sartorius AG's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Sartorius AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Cyclically Adjusted PB Ratio falls into.


;
;

Sartorius AG Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sartorius AG's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=259.02/28.80
=8.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Sartorius AG's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=42.43/127.7792*127.7792
=42.430

Current CPI (Mar. 2025) = 127.7792.

Sartorius AG Quarterly Data

Book Value per Share CPI Adj_Book
201506 7.817 100.417 9.947
201509 8.243 100.417 10.489
201512 8.247 99.717 10.568
201603 8.671 100.017 11.078
201606 8.527 100.717 10.818
201609 8.938 101.017 11.306
201612 8.941 101.217 11.287
201703 9.563 101.417 12.049
201706 9.510 102.117 11.900
201709 10.396 102.717 12.933
201712 10.691 102.617 13.312
201803 11.444 102.917 14.209
201806 11.008 104.017 13.523
201809 11.601 104.718 14.156
201812 12.320 104.217 15.105
201903 12.275 104.217 15.050
201906 12.747 105.718 15.407
201909 13.329 106.018 16.065
201912 13.166 105.818 15.898
202003 13.842 105.718 16.731
202006 13.997 106.618 16.775
202009 15.190 105.818 18.343
202012 18.341 105.518 22.210
202103 19.600 107.518 23.294
202106 21.484 108.486 25.305
202109 21.221 109.435 24.778
202112 20.815 110.384 24.095
202203 22.982 113.968 25.767
202206 25.743 115.760 28.416
202209 27.166 118.818 29.215
202212 30.809 119.345 32.986
202303 30.158 122.402 31.483
202306 32.254 123.140 33.469
202309 32.247 124.195 33.178
202312 32.960 123.773 34.027
202403 42.443 125.038 43.373
202406 42.209 125.882 42.845
202409 42.903 126.198 43.441
202412 41.935 127.041 42.179
202503 42.430 127.779 42.430

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sartorius AG  (OTCPK:SUVPF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sartorius AG Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.